✦ LIBER ✦

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

✍ Scribed by Adolf Stiehl; Siegfried Walker; Lieselotte Stiehl; Gerda Rudolph; Walter J. Hofmann; Lorenz Theilmann

Book ID: 118566363
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 610 KB
Volume: 20
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80467-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective, randomized-controlled pil

A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis

✍ R. K. Sterling; J. J. Salvatori; V. A. Luketic; A. J. Sanyal; A. S. Fulcher; R. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

A two-year prospective study of the effe

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis–associated liver disease

✍ Anders Lindblad; Hans Glaumann; Birgitta Strandvik 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 1 views

The efficacy of 2 years of treatment with ursodeoxycholic acid (UDCA) in cystic fibrosis (CF)-associated liver disease was evaluated by liver biopsies and liver function tests in 10 patients aged 8 to 28 years. The metabolism of UDCA was investigated by analysis of urinary bile acids with fast atom